chevron_leftBack
As of 24 April 2025, CRISM Therapeutics Corp. has a market cap of $4.12M USD, ranking #36123 globally and #12 in Virgin Islands, British. It ranks #3650 in the Healthcare sector, and #1221 in the Biotechnology industry.
Key Stats
Market Cap
$4.12MUSD
3.1M GBP
Enterprise Value
$1.65MUSD
1.24M GBP
Revenue (TTM)
-$41.13KUSD
-31.0K GBP
Net Income (TTM)
-$9.97MUSD
-7.51M GBP
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Robin Young
open_in_new
Employees
4
Founded
2016
Website
crismtherapeutics.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -13% | -14% | 46% | 5.6% | 7.5% | -34% |
Upcoming Earnings
Earnings Date
Fri, May 9
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
CRTX
Crism Therapeutics Corp
ISIN: VGG042401262
Shares Out.:
Shares Outstanding:
8.705M1
Shares Float:
8.66M2
|
10 GBX |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About CRISM Therapeutics Corp.
CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
Country |
|---|---|---|
Portage Biotech Inc.
NASDAQ: PRTG
|
$14.78M
259%
|
